Article
Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy.
Genetic testing and molecular biomarkers - 1 Jun 2015
Rapti Emmanouela, Gazouli Maria, Legaki Evangelia, Karamanolis George, Thomas Diamantis, Marinos Evangelos, Papaconstantinou Ioannis
Abstract excerpt
BACKGROUND/AIM: Recent evidence suggests that survivin, a member of the inhibitors of apoptosis family that prevents cell death and regulates cell division is implicated in the pathogenesis of inflammatory bowel disease (IBD). The aim of the study was to identify a possible association between individual genetic variation, IBD susceptibility, and response to infliximab (IFX). MATERIAL AND METHODS: The expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
